Dermot O'Callaghan
Dermot O'Callaghan
Okänd anknytning
Verifierad e-postadress på
Citeras av
Citeras av
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension
M Humbert, O Sitbon, A Yaïci, D Montani, DS O'callaghan, X Jaïs, ...
European Respiratory Journal 36 (3), 549-555, 2010
Pulmonary arterial hypertension in patients treated by dasatinib
D Montani, E Bergot, S Günther, L Savale, A Bergeron, A Bourdin, ...
Circulation 125 (17), 2128-2137, 2012
Pulmonary arterial hypertension in patients treated by dasatinib
D Montani, E Bergot, S Günther, L Savale, A Bergeron, A Bourdin, ...
Circulation 125 (17), 2128-2137, 2012
A hemodynamic study of pulmonary hypertension in sickle cell disease
F Parent, D Bachir, J Inamo, F Lionnet, F Driss, G Loko, A Habibi, ...
New England Journal of Medicine 365 (1), 44-53, 2011
Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying an ACVRL1 (ALK1) Mutation
B Girerd, D Montani, F Coulet, B Sztrymf, A Yaici, X Jaïs, D Tregouet, ...
American journal of respiratory and critical care medicine 181 (8), 851-861, 2010
The role of inflammation in the pathogenesis of non-small cell lung cancer
DS O'Callaghan, D O'Donnell, F O'Connell, KJ O'Byrne
Journal of thoracic oncology 5 (12), 2024-2036, 2010
A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma
G Garcia, A Magnan, R Chiron, C Contin-Bordes, P Berger, C Taillé, ...
Chest 144 (2), 411-419, 2013
Treatment of pulmonary arterial hypertension with targeted therapies
DS O'callaghan, L Savale, D Montani, X Jaïs, O Sitbon, G Simonneau, ...
Nature Reviews Cardiology 8 (9), 526-538, 2011
Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: an observational study
K Kemp, L Savale, DS O'Callaghan, X Jaïs, D Montani, M Humbert, ...
The Journal of heart and lung transplantation 31 (2), 150-158, 2012
Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension
L Savale, R Magnier, J Le Pavec, X Jaïs, D Montani, DS O'Callaghan, ...
European Respiratory Journal 41 (1), 96-103, 2013
Pulmonary veno-occlusive disease: recent progress and current challenges
D Montani, DS O’Callaghan, L Savale, X Jaïs, A Yaïci, S Maitre, ...
Respiratory medicine 104, S23-S32, 2010
Combination therapy and new types of agents for pulmonary arterial hypertension
D O'Callaghan, SP Gaine
Clinics in chest medicine 28 (1), 169-185, 2007
Pulmonary hypertension in patients with neurofibromatosis type I
D Montani, F Coulet, B Girerd, M Eyries, E Bergot, H Mal, G Biondi, ...
Medicine 90 (3), 201-211, 2011
Characterization of pulmonary arterial hypertension patients walking more than 450 m in 6 min at diagnosis
B Degano, O Sitbon, L Savale, G Garcia, DS O'Callaghan, X Jaïs, ...
Chest 137 (6), 1297-1303, 2010
Pulmonary veno-occlusive disease: advances in clinical management and treatments
A Huertas, B Girerd, P Dorfmuller, D O’Callaghan, M Humbert, D Montani, ...
Expert review of respiratory medicine 5 (2), 217-231, 2011
A critical analysis of survival in pulmonary arterial hypertension
DS O'Callaghan, M Humbert
European Respiratory Review 21 (125), 218-222, 2012
Pulmonary veno-occlusive disease: the bete noire of pulmonary hypertension in connective tissue diseases?
DS O’Callaghan, P Dorfmuller, X Jaïs, L Mouthon, O Sitbon, G Simonneau, ...
La Presse Médicale 40 (1), e87-e100, 2011
Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre
D Montani, DS O'Callaghan, X Jaïs, L Savale, D Natali, A Redzepi, ...
European Respiratory Review 18 (114), 272-290, 2009
Current management approaches to portopulmonary hypertension
L Savale, DS O’Callaghan, R Magnier, J Le Pavec, P Hervé, X Jaïs, ...
International Journal of Clinical Practice 65, 11-18, 2011
Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer
DS O'Callaghan, E Rexhepaj, K Gately, L Coate, D Delaney, ...
European Respiratory Journal 46 (6), 1762-1772, 2015
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20